A study from Switzerland presented at the 2005 European Congress of Radiology found that radiologists have a supersensibility that enables them to mentally create 3D representations of objects.
A study from Switzerland presented at the 2005 European Congress of Radiology found that radiologists have a supersensibility that enables them to mentally create 3D representations of objects.
Dr. Sven Haller and colleagues from University Hospital Basel asked a group of 24 people, half of whom were experienced radiologists, to differentiate between original and manipulated images. The visual cues were both radiographic and nonradiographic in nature.
Functional MRI showed that radiologists' brains reacted more strongly to radiologic images than did the brains of controls. Haller suggested that radiologic experience modifies neuronal representation, giving radiologists visual powers beyond mere mortals.
The researchers did not test whether radiologists are faster than a speeding bullet or more powerful than a locomotive.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.